Qilian International Holding Group — Company Overview, News & Financial Data

Qilian International Holding Group (NASDAQ:QLI) is a diversified company focused on the development, manufacture, and sales of pharmaceutical and chemical products. With operations based in China, Qilian International extends its expertise across areas such as licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD), and heparin products, aiming to cater to a broad range of healthcare needs. The company's projects span from the extraction and processing of raw materials to the development of innovative healthcare solutions, reflecting a commitment to high-quality products and the well-being of its customers. Qilian International's objectives are anchored in expanding its market presence, pioneering research and development in the pharmaceutical and chemical sectors, and driving sustainable growth while maintaining environmental stewardship.